Metraipolis › archive › dc_dd56d4f94fb3

Real-world outcomes and safety of colistin therapy in children with multidrug-resistant gram-negative infections: a nine-year experience — Europe PMC PMID:41857435

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41857435
DOI
10.1007/s00431-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-04T04:05:22.830Z
SHA-256 of the archived text
b34bb6212ea788b01e82946ebbde764bb6730add18add97dc15a81cf9aa74f84
Stable URL of this page
https://metraipolis.com/documento/dc_dd56d4f94fb3

How to cite

Real-world outcomes and safety of colistin therapy in children with multidrug-resistant gram-negative infections: a nine-year experience — Europe PMC PMID:41857435 — Europe PMC (en), https://europepmc.org/article/MED/41857435 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd56d4f94fb3 (Metraipolis archive dc_dd56d4f94fb3, sha256 b34bb6212ea788b01e82946ebbde764bb6730add18add97dc15a81cf9aa74f84)
BibTeX
@misc{dcdd56d4f94fb3,
  title = {Real-world outcomes and safety of colistin therapy in children with multidrug-resistant gram-negative infections: a nine-year experience — Europe PMC PMID:41857435},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41857435},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd56d4f94fb3; sha256 b34bb6212ea788b01e82946ebbde764bb6730add18add97dc15a81cf9aa74f84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41857435. Agents can read the archived copy with the MCP tool read_document.